$9.88
0.212.17%
In chiusura: -
$9.88
0.000.00%
After hour: 4:01 PM EDT
Fennec Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Fennec Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FENC | Fennec Pharmaceuticals | -$0.21 | $0.05 | — | — | $6.97M | $14.70M | — | — | 11/06/2025 | |
FENC | Fennec Pharmaceuticals | -$0.20 | -$0.04 | -$0.11 | -175.00% | $7.26M | $9.53M | $9.65M | 1.25% | 08/14/2025 | |
FENC | Fennec Pharmaceuticals | $0.41 | -$0.09 | -$0.04 | 55.56% | $25.38M | $8.18M | $8.75M | 6.98% | 05/13/2025 | |
FENC | Fennec Pharmaceuticals | -$0.10 | -$0.13 | -$0.06 | 53.85% | $9.73M | $16.42M | $7.92M | -51.74% | 03/10/2025 | |
FENC | Fennec Pharmaceuticals | -$0.07 | -$0.10 | -$0.21 | -110.00% | $6.51M | $8.82M | $6.97M | -20.93% | 11/07/2024 | |
FENC | Fennec Pharmaceuticals | -$0.21 | -$0.03 | -$0.20 | -566.67% | $3.33M | $11.05M | $7.26M | -34.28% | 08/13/2024 | |
FENC | Fennec Pharmaceuticals | -$0.23 | $0.26 | $0.41 | 57.69% | $1.68M | $18.88M | $25.38M | 34.41% | 05/14/2024 | |
FENC | Fennec Pharmaceuticals | -$0.26 | -$0.02 | -$0.10 | -400.00% | $1.53M | $8.67M | $9.73M | 12.28% | 03/21/2024 | |
FENC | Fennec Pharmaceuticals | -$0.31 | -$0.11 | -$0.07 | 36.36% | $0.00 | $5.42M | $6.51M | 20.20% | 11/06/2023 | |
FENC | Fennec Pharmaceuticals | -$0.19 | -$0.16 | -$0.21 | -31.25% | $0.00 | $3.73M | $3.33M | -10.86% | 08/03/2023 | |
FENC | Fennec Pharmaceuticals | -$0.14 | -$0.21 | -$0.23 | -9.52% | $0.00 | $1.85M | $1.68M | -9.35% | 05/11/2023 | |
FENC | Fennec Pharmaceuticals | -$0.18 | -$0.26 | -$0.26 | 0.00% | $0.00 | $740.00K | $1.53M | 107.43% | 03/30/2023 | |
FENC | Fennec Pharmaceuticals | -$0.16 | — | -$0.31 | — | $0.00 | — | $0.00 | — | 11/11/2022 | |
FENC | Fennec Pharmaceuticals | -$0.15 | -$0.14 | -$0.19 | -35.71% | $0.00 | — | $0.00 | — | 08/12/2022 | |
FENC | Fennec Pharmaceuticals | -$0.18 | — | -$0.14 | — | $0.00 | — | $0.00 | — | 05/12/2022 | |
FENC | Fennec Pharmaceuticals | -$0.13 | $0.75 | -$0.18 | -124.00% | $170.00K | $33.33M | $0.00 | -100.00% | 02/28/2022 | |
FENC | Fennec Pharmaceuticals | -$0.24 | — | -$0.16 | — | $0.00 | — | $0.00 | — | 11/10/2021 | |
FENC | Fennec Pharmaceuticals | -$0.21 | -$0.19 | -$0.15 | 21.05% | $0.00 | — | $0.00 | — | 08/10/2021 | |
FENC | Fennec Pharmaceuticals | -$0.19 | -$0.13 | -$0.18 | -38.46% | $0.00 | — | $0.00 | — | 05/13/2021 | |
FENC | Fennec Pharmaceuticals | -$0.18 | — | -$0.13 | — | $0.00 | — | $170.00K | — | 03/30/2021 | |
FENC | Fennec Pharmaceuticals | -$0.09 | — | -$0.24 | — | $0.00 | — | $0.00 | — | 11/16/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-14 | $-0.11 | $-0.04 | -175.0 % |
Q1 | 2025-05-13 | $-0.04 | $-0.09 | 55.6 % |
Q4 | 2025-03-10 | $-0.06 | $-0.13 | 53.8 % |
Q3 | 2024-11-07 | $-0.21 | $-0.10 | -110.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-14 | $9.65M | $9.53M | 1.25 % |
Q1 | 2025-05-13 | $8.75M | $8.18M | 6.98 % |
Q4 | 2025-03-10 | $7.93M | $16.42M | -51.7 % |
Q3 | 2024-11-07 | $6.97M | $8.82M | -20.9 % |
Si prevede che Fennec Pharmaceuticals (FENC) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.11, che mancato la stima di $-0.04.
Le entrate effettive sono state $9.7M, che superato la stima di $9.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.